PL313113A1 - Novel pharmaceutical agent for oral administration containing progesterone and polyethylene glycol - Google Patents

Novel pharmaceutical agent for oral administration containing progesterone and polyethylene glycol

Info

Publication number
PL313113A1
PL313113A1 PL94313113A PL31311394A PL313113A1 PL 313113 A1 PL313113 A1 PL 313113A1 PL 94313113 A PL94313113 A PL 94313113A PL 31311394 A PL31311394 A PL 31311394A PL 313113 A1 PL313113 A1 PL 313113A1
Authority
PL
Poland
Prior art keywords
polyethylene glycol
oral administration
pharmaceutical agent
novel pharmaceutical
administration containing
Prior art date
Application number
PL94313113A
Other languages
English (en)
Inventor
Karen Susanne Gram
Annelise Jensen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of PL313113A1 publication Critical patent/PL313113A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
PL94313113A 1993-08-20 1994-08-19 Novel pharmaceutical agent for oral administration containing progesterone and polyethylene glycol PL313113A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK93950A DK95093D0 (da) 1993-08-20 1993-08-20 Farmaceutisk formulering indeholdende et hormon
PCT/DK1994/000310 WO1995005807A1 (en) 1993-08-20 1994-08-19 A novel pharmaceutical for oral administration comprising progesterone and a polyethylene glycol together with an excipient

Publications (1)

Publication Number Publication Date
PL313113A1 true PL313113A1 (en) 1996-06-10

Family

ID=8099329

Family Applications (1)

Application Number Title Priority Date Filing Date
PL94313113A PL313113A1 (en) 1993-08-20 1994-08-19 Novel pharmaceutical agent for oral administration containing progesterone and polyethylene glycol

Country Status (17)

Country Link
EP (1) EP0789560A1 (da)
JP (1) JPH09501682A (da)
KR (1) KR960703570A (da)
CN (1) CN1132478A (da)
AU (1) AU7530594A (da)
BR (1) BR9407306A (da)
CA (1) CA2169840A1 (da)
CZ (1) CZ42596A3 (da)
DK (1) DK95093D0 (da)
FI (1) FI960749A7 (da)
HU (1) HUT74167A (da)
LT (1) LT4043B (da)
NO (1) NO960653L (da)
NZ (1) NZ271617A (da)
PL (1) PL313113A1 (da)
SK (1) SK19396A3 (da)
WO (1) WO1995005807A1 (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2772617B1 (fr) * 1997-12-19 2001-03-09 Besins Iscovesco Lab Comprime de progesterone et son procede de preparation
FR2775599B1 (fr) 1998-03-09 2001-08-17 Besins Iscovesco Lab Composition pharmaceutique a base de progesterone naturelle de synthese et d'oestradiol et son procede de preparation
GB2339114B (en) * 1998-06-30 2003-03-05 Ericsson Telefon Ab L M Secure messaging in mobile telephones
IL127129A (en) * 1998-11-18 2004-06-01 Ferring Bv Method for preparation of progesterone tablets for vaginal delivery and tablets so prepared
ES2319750T3 (es) * 1999-08-31 2009-05-12 Bayer Schering Pharma Aktiengesellschaft Composicion farmaceutica que comprende etinilestradiol y drospirenona para usar como anticonceptivo.
US6544553B1 (en) * 1999-12-28 2003-04-08 Watson Pharmaceuticals, Inc. Dosage forms and methods for oral delivery of progesterone
FI20002768L (fi) * 2000-12-18 2002-06-19 Licentia Oy Enteropäällysteisiä lääkekoostumuksia ja niiden valmistus
JP2005526083A (ja) * 2002-03-14 2005-09-02 ワトソン ファーマシューティカルズ， インコーポレイテッド プロゲステロンの経口薬物送達システム
WO2004096405A1 (en) * 2003-04-29 2004-11-11 Akzo Nobel N.V. Antisolvent solidification process
DK1874278T3 (da) 2005-04-28 2009-09-28 Wyeth Corp Sammensætninger indeholdende mikroniseret tanaproget
DE202007019049U1 (de) * 2007-11-05 2010-05-12 Bayer Schering Pharma Aktiengesellschaft Verwendung eines Gestagens in Kombination mit einem Estrogen zur Prophylaxe der Laktoseintoleranz bei der oralen Kontrazeption
US20110312928A1 (en) * 2010-06-18 2011-12-22 Lipocine Inc. Progesterone Containing Oral Dosage Forms and Related Methods
US9375437B2 (en) 2010-06-18 2016-06-28 Lipocine Inc. Progesterone containing oral dosage forms and kits
US8951996B2 (en) 2011-07-28 2015-02-10 Lipocine Inc. 17-hydroxyprogesterone ester-containing oral compositions and related methods
CA2856520C (en) * 2011-11-23 2021-04-06 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
AR100562A1 (es) 2014-05-22 2016-10-12 Therapeuticsmd Inc Composición farmacéutica de estradiol y progesterona para terapia de reemplazo hormonal
WO2016210003A2 (en) 2015-06-22 2016-12-29 Lipocine Inc. 17-hydroxyprogesterone ester-containing oral compositions and related methods
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3862311A (en) * 1971-04-12 1975-01-21 Ciba Geigy Corp Novel method of enhancing progestational endometrial proliferation with progesterone
FR2408345A1 (fr) 1976-11-30 1979-06-08 Besins Jean Louis Nouvelle composition a action anti-conceptionnelle
GB2091552A (en) 1980-09-09 1982-08-04 Carnrick G W Ltd Use of progesterone for the treatment of post-menopausal women
US4963540A (en) * 1986-04-16 1990-10-16 Maxson Wayne S Method for treatment of premenstrual syndrome
US5084277A (en) 1988-08-30 1992-01-28 Greco John C Vaginal progesterone tablet
US5116619A (en) 1988-08-30 1992-05-26 Lee Roy Morgan Vaginal progesterone tablet
WO1990008537A1 (en) * 1989-02-06 1990-08-09 Abbott Laboratories Pharmaceutical compositions for oral administration
US5223268A (en) * 1991-05-16 1993-06-29 Sterling Drug, Inc. Low solubility drug-coated bead compositions

Also Published As

Publication number Publication date
JPH09501682A (ja) 1997-02-18
CN1132478A (zh) 1996-10-02
CA2169840A1 (en) 1995-03-02
NZ271617A (en) 1996-11-26
BR9407306A (pt) 1996-10-08
EP0789560A1 (en) 1997-08-20
HU9600376D0 (en) 1996-04-29
KR960703570A (ko) 1996-08-31
HUT74167A (en) 1996-11-28
AU7530594A (en) 1995-03-21
FI960749A0 (fi) 1996-02-19
LT4043B (en) 1996-09-25
WO1995005807A1 (en) 1995-03-02
LT96010A (da) 1996-06-25
FI960749L (fi) 1996-02-19
NO960653D0 (no) 1996-02-19
DK95093D0 (da) 1993-08-20
CZ42596A3 (en) 1996-06-12
FI960749A7 (fi) 1996-02-19
SK19396A3 (en) 1997-03-05
NO960653L (no) 1996-02-19

Similar Documents

Publication Publication Date Title
PL313113A1 (en) Novel pharmaceutical agent for oral administration containing progesterone and polyethylene glycol
ZA941002B (en) Pharmaceutical compositions in semisold form and a device for administration thereof
ZA942804B (en) Oral drug delivery compositions and methods
IL111221A0 (en) N-alkyl-n- arylpyrimidinamine derivatives and pharmaceutical compositions containing them
IL114626A0 (en) 6-membered nitrogen-containing heteroaryl-oxazolidinones their preparation and pharmaceutical compositions containing them
IL105218A0 (en) Hexanones and pharmaceutical compositions containing them
IL116851A (en) 3-arylidene-2-oxindole derivatives and pharmaceutical compositions containing them
IL105223A0 (en) Cyclohexane-ylidenes and pharmaceutical compositions containing them
IL105221A0 (en) Cyclohexane derivatives and pharmaceutical compositions containing them
IL115097A0 (en) Pharmaceutical compositions adapted for oral administration
IL110376A0 (en) Pharmaceutical compositions containing ifetroban and methods for the preparation thereof
HUP9801749A3 (en) Nodulisporic acid derivatives and pharmaceutical compositions containing them
IL114925A (en) Glycinamide derivatives their preparation and pharmaceutical compositions containing them
AU2885892A (en) Oral pharmaceutical composition containing polyethylene glycol immunoglobulin conjugate
IL127572A (en) Pharmaceutical composition and medicament for nasal administration
IL106098A0 (en) Heteroarylnaphthalenes and pharmaceutical compositions containing them
EP0582169A3 (en) Pharmaceutical preparations for the oral administration of dihydropyridines in beverage form
IL125820A0 (en) Therapeutic agent for diabetes and a pharmaceutical composition containing the same
IL115027A (en) N-substituted phenothiazines their preparation pharmaceutical compositions containing them and their use
HUT71131A (en) Paramycin formulations for oral administration
IL104417A0 (en) Substituted dihydroindene and-acenaphthene derivatives and pharmaceutical compositions containing them
HUP9801947A3 (en) Device and process for mixing a pharmaceutical composition with another agent and method for oral administration of the pharmaceutical preparation
IL108920A0 (en) Acyloxyhexanoic acid derivatives and pharmaceutical compositions containing them
IL115982A (en) Cyclolignan derivatives and pharmaceutical compositions containing them
IL108031A0 (en) Difluoro pentapeptide derivatives and pharmaceutical compositions containing them